Pediatric Clinical Trials Market size is set to Grow at a Remarkable Pace by 2032Posted by Ganesh Shinde on April 5th, 2023  During the forecast period 2022 to 2032, the global pediatric clinical trials market is expected to grow at a value of 5.3%, according to Future Market Insights. In 2022, this market was predicted to have a global valuation of US$ 15.8 Billion, and is expected to reach a sum of US$ 26.47 Billion by 2032. The market is going to face increasing demand owing to the increase of pediatric chronic and genetic diseases all across the world. The growing need for novel vaccines and biopharmaceuticals to treat infectious diseases such as measles, polio, tuberculosis, rubella, influenza, mumps, whooping cough, malaria, chickenpox, and staphylococcus pharyngitis is expected to drive market growth. At the same time, diabetes is a big worry among today's children. The market is being driven by rising parental awareness of children clinical trials for severe infections and chronic diseases, as well as a large number of CROs doing pediatric research. In 2021, the oncology therapeutic field category had the world's second-largest revenue share. Cancer is the top cause of death in the globe. Cancer cases in children under the age of 19 are anticipated to reach 291,000 by 2040. With the increasing number of pediatric cancer cases worldwide, many hospitals and institutes are focusing on the development of therapeutic drugs, resulting in an increase in the number of pediatric clinical trials globally. Competitive Landscape Key Players:
Get More Insights@ https://www.futuremarketinsights.com/reports/pediatric-clinical-trials-market Key Segments Covered in the Pediatric Clinical Trials Market Report Pediatric Clinical Trials Market by Phase Type:
Pediatric Clinical Trials Market by Study Design:
Pediatric Clinical Trials Market by Therapeutic Areas:
Like it? Share it! More by this author |